Clearpoint Neuro, Inc.
(NASDAQ : CLPT)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
TMOThermo Fisher Scientific, Inc. -0.60%474.361.0%$995.46m
DHRDanaher Corp. 0.48%224.420.7%$673.88m
BSXBoston Scientific Corp. 1.75%34.401.0%$567.89m
MDTMedtronic Plc 1.20%113.820.6%$533.10m
ABTAbbott Laboratories 0.32%107.870.8%$499.36m
BDXBecton, Dickinson & Co. 1.79%242.771.0%$449.38m
ISRGIntuitive Surgical, Inc. 2.85%780.342.3%$400.44m
DXCMDexCom, Inc. 0.99%348.037.8%$389.88m
ALGNAlign Technology, Inc. 2.10%521.726.4%$336.96m
BAXBaxter International, Inc. 2.20%78.001.8%$298.54m
SYKStryker Corp. 2.04%239.561.3%$288.34m
QDELQuidel Corp. -3.69%193.577.7%$233.02m
AAgilent Technologies, Inc. 1.43%115.201.6%$230.22m
EWEdwards Lifesciences Corp. 2.58%85.810.4%$223.58m
IDXXIDEXX Laboratories, Inc. -0.64%457.153.8%$200.27m

Company Profile

Clearpoint Neuro, Inc. engages in the development and commercialization of innovative platforms for performing minimally invasive surgical procedures in the brain and heart. It conducts its procedures under direct, intra-procedural magnetic resonance imaging guidance. Its product platform is comprises of ClearPoint system and ClearTrace system. The company was founded by Paul A. Bottomley on March 12, 1998 and is headquartered in Irvine, CA.